21794-66-1

Usage

Uses

Used in Pharmaceutical Industry:
(1S)-1,5-anhydro-1-(1,6,7-trihydroxy-3-methoxy-9-oxo-9H-xanthen-2-yl)-D-glucitol is used as a potential pharmaceutical agent for its possible biological activities. The xanthen-2-yl group, which is a part of its structure, is known to be present in certain natural products and pharmaceuticals, suggesting that (1S)-1,5-anhydro-1-(1,6,7-trihydroxy-3-methoxy-9-oxo-9H-xanthen-2-yl)-D-glucitol could have therapeutic applications once its specific properties are fully explored and understood.
Used in Research and Development:
In the field of scientific research, (1S)-1,5-anhydro-1-(1,6,7-trihydroxy-3-methoxy-9-oxo-9H-xanthen-2-yl)-D-glucitol serves as a subject for further study. Its complex structure and the presence of the xanthen-2-yl group make it an interesting candidate for exploring new chemical reactions, synthesis methods, and potential applications in various fields, including medicine and material science.

Upstream product

• 1239694-40-6 2-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-7-hydroxy-1,3,6-trimethoxyxanthone 
• 131531-76-5 p-methylphenyl 2,3,4,6-tetra-O-benzyl-thio-β-D-glucopyranoside 
• 1152-39-2 p-methylphenyl 1-thio-β-D-glucopyranoside 
• 28244-94-2 p-tolyl-2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
• 156862-15-6 1,2,4-tris(methoxymethoxy)benzene 
• 533-73-3 1,2,4-Trihydroxybenzene 
• 80300-30-7 1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose 
• 82300-67-2 1-deoxy-1-(C-2',4',6'-trimethoxyphenyl) 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside 
• 604-69-3 β-D-glucose pentaacetate 
• 141196-74-9 1-trifluoroacetoxy-2,3,4,6-tetra-O-benzyl-α,β-D-glucopyranoside 
• 4291-69-4 2,3,4,6-Tetra-O-benzyl-D-glucopyranose 
• 4773-96-0 mangiferin 

Relevant academic research and scientific papers

Total synthesis of mangiferin, homomangiferin, and neomangiferin

Total synthesis of mangiferin, homomangiferin, and neomangiferin, three C-glycosyl xanthone natural products with a wide spectrum of pharmacological effects, has been achieved starting from 2,3,4,6-tetra-O-benzyl-α/β-d-glucopyranose. The key steps involve a stereoselective Lewis acid promoted C-glycosylation of protected phloroglucinol with tetrabenzylglucopyranosyl acetate and a highly regioselective base-induced cyclization for the construction of the core xanthone skeleton.

1, 6, 7-trihydroxy-3-methoxy dihydrogenmethylenebisphosphonate benzene pyrrole alkone -2-C-β-D method for preparing-glucopyranoside

The invention relates to the field of chemical synthesis, and specifically disclose a preparation method of 1,6,7-trihydroxy-3-methoxyl xanthone-2-C-beta-D-glucopyranoside. According to the method, mangiferin is adopted as a raw material, and 3-methoxyl mangiferin is prepared through boric acid esterification, selective methylation, and hydrolysis reactions. The method provided by the invention has the advantages of short synthesis route, high product yield, low-toxic safe reagent, low production cost, and suitability for large-scale industrial productions.

Synthesis of mangiferin, isomangiferin, and homomangiferin

Mangiferin, isomangiferin, and homomangiferin, the xanthone C-glycosides with a wide spectrum of pharmacological effects, were synthesized concisely, featuring a C-glycosylation of a xanthene derivative with perbenzylglucopyranosyl N-phenyltrifluoroacetimidate.

SYNTHESIS OF ATHYRIOL AND HOMOMANGIFERIN

Athyroil and homomangiferin have been synthesized from the corresponding no-compounds, namely, nor- athyriol and mangiferin, by selective O-methylation with dimethyl sulfate in the presence of borax and alkali, thus confirming their structures.